IGC Pharma, Inc. (IGC): Revenue
Not updated since 2025-03-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$1.27M
Year ended 2025-03-31
$1.11M
Trailing 12 months to 2025-09-30
+47.4%
3-year compound annual growth
-20.8%
5-year compound annual growth
-16.5%
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-03-31 | $1.27M | -5.5% | 2025-06-27, From 2024-04-01 |
| 2024-03-31 | $1.34M | +47.6% | 2025-06-27, From 2023-04-01 |
| 2023-03-31 | $911.0K | +129.5% | 2024-06-24, From 2022-04-01 |
| 2022-03-31 | $397.0K | -55.8% | 2023-07-07, From 2021-04-01 |
| 2021-03-31 | $898.0K | -77.9% | 2022-06-23, From 2020-04-01 |
| 2020-03-31 | $4.07M | -20.4% | 2021-06-14, From 2019-04-01 |
| 2019-03-31 | $5.12M | +133.3% | 2020-07-13, From 2018-04-01 |
| 2018-03-31 | $2.19M | +277.9% | 2019-06-14, From 2017-04-01 |
| 2017-03-31 | $580.4K | -90.9% | 2018-06-21, From 2016-04-01 |
| 2016-03-31 | $6.37M | -17.1% | 2017-07-14, From 2015-04-01 |
| 2015-03-31 | $7.68M | +237.9% | 2016-07-14, From 2014-04-01 |
| 2014-03-31 | $2.27M | -71.7% | 2015-07-14, From 2013-04-01 |
| 2013-03-31 | $8.03M | +91.2% | 2014-07-15, From 2012-04-01 |
| 2012-03-31 | $4.20M | +3.1% | 2014-07-15, From 2011-04-01 |
| 2011-03-31 | $4.07M | n/a | 2012-07-16, From 2010-04-01 |